RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
H Lundbeck A/S Stock

H Lundbeck A/S ROE 2024

H Lundbeck A/S ROE

0.07

Ticker

LUN.CO

ISIN

DK0010287234

WKN

922351

In 2024, H Lundbeck A/S's return on equity (ROE) was 0.07, a 0% increase from the 0 ROE in the previous year.

H Lundbeck A/S Aktienanalyse

What does H Lundbeck A/S do?

H Lundbeck A/S is a Danish company that was founded in 1915 by Hans Lundbeck. Since its inception, the company has focused on researching and developing medications that improve the lives of people with neuropsychiatric disorders. Lundbeck's business model is based on a clear strategy and a strong focus on the research and development of pharmaceuticals. The company has four main therapy areas: depression, anxiety disorders, Alzheimer's, and Parkinson's. Lundbeck products are sold in over 100 countries worldwide and are known for their effectiveness and high quality. Over the years, Lundbeck has also focused on developing innovative treatment methods, including research on new drugs and therapies based on neurotransmitters such as serotonin, dopamine, and norepinephrine. With the acquisition of Alder BioPharmaceuticals in 2019, Lundbeck also expanded its portfolio in the field of migraine therapy. Some of Lundbeck's most well-known products include Lexapro, Cipralex, Selincro, Abilify Maintena, and Brintellix. These medications are used in the treatment of depression, anxiety disorders, alcoholism, bipolar disorders, and migraines. In addition to selling medications, Lundbeck also provides training and support for healthcare professionals and patients. Lundbeck is also distinguished by its commitment to social engagement and works closely with nonprofit organizations to raise awareness of neuropsychiatric disorders. The company has also launched various programs to improve access to medical care in particularly affected regions. In 2020, Lundbeck exceeded 18,000 employees worldwide and had a revenue of 16.6 billion Danish kroner. Lundbeck is listed on NASDAQ OMX Copenhagen and is controlled by the Lundbeck Foundation, which holds over 70% of the company's ownership. In summary, Lundbeck is a leading company in the field of neuropsychiatric medicine and is dedicated to improving the lives of people with these serious disorders. The company has made a name for itself through its successful research and development of therapies and medications, as well as its strong focus on social engagement and corporate social responsibility. H Lundbeck A/S ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding H Lundbeck A/S's Return on Equity (ROE)

H Lundbeck A/S's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing H Lundbeck A/S's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

H Lundbeck A/S's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in H Lundbeck A/S’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about H Lundbeck A/S stock

What is the ROE (Return on Equity) of H Lundbeck A/S this year?

The ROE of H Lundbeck A/S this year is 0.07 undefined.

How has the Return on Equity (ROE) of H Lundbeck A/S developed compared to the previous year?

The ROE of H Lundbeck A/S has increased by 0% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of H Lundbeck A/S?

A high ROE indicates that H Lundbeck A/S generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of H Lundbeck A/S?

A low ROE can indicate that H Lundbeck A/S is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of H Lundbeck A/S affect the company?

A change in ROE (Return on Equity) of H Lundbeck A/S can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of H Lundbeck A/S?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of H Lundbeck A/S?

Some factors that can influence H Lundbeck A/S's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does H Lundbeck A/S pay?

Over the past 12 months, H Lundbeck A/S paid a dividend of 2.5 DKK . This corresponds to a dividend yield of about 1.45 %. For the coming 12 months, H Lundbeck A/S is expected to pay a dividend of 15.45 DKK.

What is the dividend yield of H Lundbeck A/S?

The current dividend yield of H Lundbeck A/S is 1.45 %.

When does H Lundbeck A/S pay dividends?

H Lundbeck A/S pays a quarterly dividend. This is distributed in the months of April, April, April, April.

How secure is the dividend of H Lundbeck A/S?

H Lundbeck A/S paid dividends every year for the past 10 years.

What is the dividend of H Lundbeck A/S?

For the upcoming 12 months, dividends amounting to 15.45 DKK are expected. This corresponds to a dividend yield of 8.94 %.

In which sector is H Lundbeck A/S located?

H Lundbeck A/S is assigned to the 'Health' sector.

Wann musste ich die Aktien von H Lundbeck A/S kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of H Lundbeck A/S from 3/28/2022 amounting to 2 DKK, you needed to have the stock in your portfolio before the ex-date on 3/24/2022.

When did H Lundbeck A/S pay the last dividend?

The last dividend was paid out on 3/28/2022.

What was the dividend of H Lundbeck A/S in the year 2023?

In the year 2023, H Lundbeck A/S distributed 2 DKK as dividends.

In which currency does H Lundbeck A/S pay out the dividend?

The dividends of H Lundbeck A/S are distributed in DKK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The H Lundbeck A/S stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von H Lundbeck A/S

Our stock analysis for H Lundbeck A/S Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of H Lundbeck A/S Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.